Zkusit zdarma
Zai Lab Limited

Zai Lab Limited

ZLAB
Cena:
$ 18.61
-0.49 (-2.57%)
Valuace
70
Růst
53
Zdraví
75
Souhrn Finanční data Pro investory Předpovědi Zprávy Dividendy Zisky Návštěvnost webu Akcionáři
Souhrn
Finanční data
Pro investory
Předpovědi
Zprávy
Dividendy
Zisky
Návštěvnost webu
Akcionáři

Zprávy

Zahraniční články
Tiskové zprávy
Dokumenty ke stáhnutí
Zai Lab Q1 Earnings Call Highlights

Zai Lab Q1 Earnings Call Highlights

5:07 09-05-2026

Zai Lab NASDAQ: ZLAB reported a year-over-year decline in first-quarter 2026 product revenue as pres...

Zai Lab Limited (ZLAB) Q1 2026 Earnings Call Transcript

Zai Lab Limited (ZLAB) Q1 2026 Earnings Call Transcript

22:41 07-05-2026

Zai Lab Limited (ZLAB) Q1 2026 Earnings Call Transcript...

Zai Lab Limited (ZLAB) Reports Q1 Earnings: What Key Metrics Have to Say

Zai Lab Limited (ZLAB) Reports Q1 Earnings: What Key Metrics Have to Say

10:31 07-05-2026

Although the revenue and EPS for Zai Lab Limited (ZLAB) give a sense of how its business performed i...

Zai Lab Announces First Quarter 2026 Financial Results and Recent Corporate Updates

Zai Lab Announces First Quarter 2026 Financial Results and Recent Corporate Updates

6:00 07-05-2026

SHANGHAI & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today annou...

Zai Lab to Announce First Quarter 2026 Financial Results and Recent Corporate Updates on May 7, 2026

Zai Lab to Announce First Quarter 2026 Financial Results and Recent Corporate Updates on May 7, 2026

7:30 22-04-2026

SHANGHAI & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today annou...

Zai Lab Limited (ZLAB) Discusses Intracranial Activity of a New Therapy in Small Cell Lung Cancer With Brain Metastases Transcript

Zai Lab Limited (ZLAB) Discusses Intracranial Activity of a New Therapy in Small Cell Lung Cancer With Brain Metastases Transcript

19:11 20-04-2026

Zai Lab Limited (ZLAB) Discusses Intracranial Activity of a New Therapy in Small Cell Lung Cancer Wi...

Zai Lab (NASDAQ:ZLAB) Sees Strong Trading Volume – Still a Buy?

Zai Lab (NASDAQ:ZLAB) Sees Strong Trading Volume – Still a Buy?

3:59 19-04-2026

Zai Lab Limited Unsponsored ADR (NASDAQ: ZLAB - Get Free Report) saw unusually-strong trading volume...

Zai Lab Presents New Preclinical Data Suggesting ZL-1503, an IL-13/IL-31Rα Bispecific Antibody, Provides Rapid Itch Relief and Reduction in Inflammation in Atopic Diseases

Zai Lab Presents New Preclinical Data Suggesting ZL-1503, an IL-13/IL-31Rα Bispecific Antibody, Provides Rapid Itch Relief and Reduction in Inflammation in Atopic Diseases

9:00 18-04-2026

SHANGHAI & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today annou...

Zai Lab Presents New Data Demonstrating Zocilurtatug Pelitecan (Zoci) Induces Rapid and Robust Intracranial Responses in Small Cell Lung Cancer with Brain Metastases and Promising Activity in Other Neuroendocrine Carcinomas

Zai Lab Presents New Data Demonstrating Zocilurtatug Pelitecan (Zoci) Induces Rapid and Robust Intracranial Responses in Small Cell Lung Cancer with Brain Metastases and Promising Activity in Other Neuroendocrine Carcinomas

15:01 17-04-2026

SHANGHAI & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today annou...

Zai Lab: Xacduro And ZL-1310 Drive Growth Narrative

Zai Lab: Xacduro And ZL-1310 Drive Growth Narrative

9:02 06-04-2026

On March 31, Zai Lab Limited stock finally broke out of its downward trend. One of the key factors b...

Ying Du Sells 5,576 Shares of Zai Lab (NASDAQ:ZLAB) Stock

Ying Du Sells 5,576 Shares of Zai Lab (NASDAQ:ZLAB) Stock

6:26 05-04-2026

Zai Lab Limited Unsponsored ADR (NASDAQ: ZLAB - Get Free Report) CEO Ying Du sold 5,576 shares of th...

Yajing Chen Sells 5,199 Shares of Zai Lab (NASDAQ:ZLAB) Stock

Yajing Chen Sells 5,199 Shares of Zai Lab (NASDAQ:ZLAB) Stock

6:26 05-04-2026

Zai Lab Limited Unsponsored ADR (NASDAQ: ZLAB - Get Free Report) CFO Yajing Chen sold 5,199 shares o...

Zai Lab Limited Unsponsored ADR (NASDAQ:ZLAB) Given Average Recommendation of “Moderate Buy” by Brokerages

Zai Lab Limited Unsponsored ADR (NASDAQ:ZLAB) Given Average Recommendation of “Moderate Buy” by Brokerages

4:43 01-04-2026

Shares of Zai Lab Limited Unsponsored ADR (NASDAQ: ZLAB - Get Free Report) have received an average ...

Zai Lab Limited (ZLAB) Presents at Citi's 2026 Virtual Oncology Leadership Summit Transcript

Zai Lab Limited (ZLAB) Presents at Citi's 2026 Virtual Oncology Leadership Summit Transcript

16:44 20-02-2026

Zai Lab Limited (ZLAB) Presents at Citi's 2026 Virtual Oncology Leadership Summit Transcript...

Zai Lab Limited Unsponsored ADR (NASDAQ:ZLAB) Receives $51.59 Consensus Price Target from Analysts

Zai Lab Limited Unsponsored ADR (NASDAQ:ZLAB) Receives $51.59 Consensus Price Target from Analysts

2:24 13-02-2026

Shares of Zai Lab Limited Unsponsored ADR (NASDAQ: ZLAB - Get Free Report) have been assigned a cons...

Zai Lab to Announce Fourth Quarter and Full Year 2025 Financial Results and Recent Corporate Updates on February 26, 2026

Zai Lab to Announce Fourth Quarter and Full Year 2025 Financial Results and Recent Corporate Updates on February 26, 2026

8:30 10-02-2026

SHANGHAI & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today annou...

Zai Lab Limited (ZLAB) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Zai Lab Limited (ZLAB) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

22:15 13-01-2026

Zai Lab Limited (ZLAB) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript...

Zai Lab Announces National Medical Products Administration (NMPA) Approval of AUGTYRO™ (repotrectinib) for Patients with NTRK-Positive Solid Tumors

Zai Lab Announces National Medical Products Administration (NMPA) Approval of AUGTYRO™ (repotrectinib) for Patients with NTRK-Positive Solid Tumors

7:30 06-01-2026

SHANGHAI & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today annou...

Zai Lab (NASDAQ:ZLAB) Insider Rafael Amado Sells 10,787 Shares

Zai Lab (NASDAQ:ZLAB) Insider Rafael Amado Sells 10,787 Shares

5:38 03-01-2026

Zai Lab Limited Unsponsored ADR (NASDAQ: ZLAB - Get Free Report) insider Rafael Amado sold 10,787 sh...

Zai Lab Announces Approval of COBENFY (xanomeline and trospium chloride) in China, a First-in-Class Therapy for Schizophrenia

Zai Lab Announces Approval of COBENFY (xanomeline and trospium chloride) in China, a First-in-Class Therapy for Schizophrenia

7:30 23-12-2025

SHANGHAI & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today annou...

close

ZAI LAB HIGHLIGHTS STRATEGIC PRIORITIES AND GLOBAL PIPELINE PROGRESS AT 44TH ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE

13-01-2026
SHANGHAI & CAMBRIDGE, MASS.--(BUSINESS WIRE)--ZAI LAB LIMITED (NASDAQ: ZLAB; HKEX: 9688) TODAY PROVI...
Více zde

ZAI LAB ANNOUNCES NATIONAL MEDICAL PRODUCTS ADMINISTRATION (NMPA) APPROVAL OF AUGTYRO™ (REPOTRECTINIB) FOR PATIENTS WITH NTRK-POSITIVE SOLID TUMORS

06-01-2026
SHANGHAI & CAMBRIDGE, MASS.--(BUSINESS WIRE)--ZAI LAB LIMITED (NASDAQ: ZLAB; HKEX: 9688) TODAY ANNOU...
Více zde

ZAI LAB TO PRESENT AT 44TH ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE

05-01-2026
SHANGHAI & CAMBRIDGE, MASS.--(BUSINESS WIRE)--ZAI LAB LIMITED (NASDAQ: ZLAB; HKEX: 9688) TODAY ANNOU...
Více zde

ZAI LAB ANNOUNCES APPROVAL OF COBENFY (XANOMELINE AND TROSPIUM CHLORIDE) IN CHINA, A FIRST-IN-CLASS THERAPY FOR SCHIZOPHRENIA

23-12-2025
SHANGHAI & CAMBRIDGE, MASS.--(BUSINESS WIRE)--ZAI LAB LIMITED (NASDAQ: ZLAB; HKEX: 9688) TODAY ANNOU...
Více zde

ZAI LAB ANNOUNCES DOSING OF FIRST PARTICIPANT IN GLOBAL PHASE 1/1B STUDY OF ZL-1503, AN IL-13/IL-31R BISPECIFIC ANTIBODY FOR THE TREATMENT OF ATOPIC DERMATITIS

08-12-2025
SHANGHAI & CAMBRIDGE, MASS.--(BUSINESS WIRE)--ZAI LAB LIMITED (NASDAQ: ZLAB; HKEX: 9688) TODAY ANNOU...
Více zde

ZAI LAB ANNOUNCES UPDATES TO CHINA'S NATIONAL REIMBURSEMENT DRUG LIST

07-12-2025
SHANGHAI & CAMBRIDGE, MASS.--(BUSINESS WIRE)--ZAI LAB LIMITED (NASDAQ: ZLAB; HKEX: 9688) TODAY ANNOU...
Více zde

ZAI LAB ANNOUNCES THIRD QUARTER 2025 FINANCIAL RESULTS AND RECENT CORPORATE UPDATES

06-11-2025
SHANGHAI & CAMBRIDGE, MASS.--(BUSINESS WIRE)--ZAI LAB LIMITED (NASDAQ: ZLAB; HKEX: 9688) TODAY ANNOU...
Více zde

ZAI LAB ANNOUNCES PARTICIPATION IN INVESTOR CONFERENCES IN NOVEMBER AND DECEMBER 2025

31-10-2025
SHANGHAI & CAMBRIDGE, MASS.--(BUSINESS WIRE)--ZAI LAB LIMITED (NASDAQ: ZLAB; HKEX: 9688) TODAY ANNOU...
Více zde

ZAI LAB ANNOUNCES UPDATED PHASE 1 DATA FOR ZOCILURTATUG PELITECAN (FORMERLY ZL-1310), DEMONSTRATING POTENTIAL AS A FIRST-IN-CLASS/BEST-IN-CLASS DLL3-TARGETED ADC FOR SMALL CELL LUNG CANCER, AND INITIATION OF GLOBAL PHASE 3 REGISTRATIONAL STUDY

24-10-2025
SHANGHAI & CAMBRIDGE, MASS.--(BUSINESS WIRE)--ZAI LAB LIMITED (NASDAQ: ZLAB; HKEX: 9688) TODAY ANNOU...
Více zde

ZAI LAB TO ANNOUNCE THIRD QUARTER 2025 FINANCIAL RESULTS AND RECENT CORPORATE UPDATES ON NOVEMBER 6, 2025

15-10-2025
SHANGHAI & CAMBRIDGE, MASS.--(BUSINESS WIRE)--ZAI LAB LIMITED (NASDAQ: ZLAB; HKEX: 9688) TODAY ANNOU...
Více zde

ZAI LAB ANNOUNCES ORAL PRESENTATION OF UPDATED DATA FROM GLOBAL PHASE 1 TRIAL OF ZOCILURTATUG PELITECAN (ZL-1310), A POTENTIAL FIRST-IN-CLASS DLL3-TARGETED ADC, AT 2025 AACR-NCI-EORTC CONFERENCE

13-10-2025
SHANGHAI & CAMBRIDGE, MASS.--(BUSINESS WIRE)--ZAI LAB LIMITED (NASDAQ: ZLAB; HKEX: 9688) TODAY ANNOU...
Více zde

INVESTOR ALERT: POMERANTZ LAW FIRM INVESTIGATES CLAIMS ON BEHALF OF INVESTORS OF ZAI LAB LIMITED - ZLAB

06-09-2025
NEW YORK, SEPT. 06, 2025 (GLOBE NEWSWIRE) -- POMERANTZ LLP IS INVESTIGATING CLAIMS ON BEHALF OF INVE...
Více zde

ZAI LAB ANNOUNCES APPROVAL OF TIVDAK® FOR PATIENTS WITH RECURRENT OR METASTATIC CERVICAL CANCER IN HONG KONG

01-09-2025
SHANGHAI & CAMBRIDGE, MASS.--(BUSINESS WIRE)--ZAI LAB LIMITED (NASDAQ: ZLAB; HKEX: 9688) TODAY ANNOU...
Více zde

ZAI LAB ANNOUNCES PARTICIPATION IN INVESTOR CONFERENCES IN SEPTEMBER 2025

28-08-2025
SHANGHAI & CAMBRIDGE, MASS.--(BUSINESS WIRE)--ZAI LAB LIMITED (NASDAQ: ZLAB; HKEX: 9688) TODAY ANNOU...
Více zde

ZAI LAB ANNOUNCES CHINA NATIONAL MEDICAL PRODUCTS ADMINISTRATION GRANTS INNOVATIVE MEDICAL DEVICE DESIGNATION FOR TUMOR TREATING FIELDS FOR PATIENTS WITH PANCREATIC CANCER

19-08-2025
SHANGHAI & CAMBRIDGE, MASS.--(BUSINESS WIRE)--ZAI LAB LIMITED (NASDAQ: ZLAB; HKEX: 9688) TODAY ANNOU...
Více zde

ZAI LAB ESTABLISHES ONCOLOGY SCIENTIFIC ADVISORY BOARD

13-08-2025
SHANGHAI & CAMBRIDGE, MASS.--(BUSINESS WIRE)--ZAI LAB LIMITED (NASDAQ: ZLAB; HKEX: 9688) TODAY ANNOU...
Více zde

ZAI LAB ANNOUNCES SECOND QUARTER 2025 FINANCIAL RESULTS AND RECENT CORPORATE UPDATES

07-08-2025
SHANGHAI & CAMBRIDGE, MASS.--(BUSINESS WIRE)--ZAI LAB LIMITED (NASDAQ: ZLAB; HKEX: 9688) TODAY ANNOU...
Více zde

ZAI LAB TO ANNOUNCE SECOND QUARTER 2025 FINANCIAL RESULTS AND RECENT CORPORATE UPDATES ON AUGUST 7, 2025

10-07-2025
SHANGHAI & CAMBRIDGE, MASS.--(BUSINESS WIRE)--ZAI LAB LIMITED (NASDAQ: ZLAB; HKEX: 9688) TODAY ANNOU...
Více zde

ZAI LAB ANNOUNCES POSITIVE TOPLINE PHASE 3 RESULTS FOR BEMARITUZUMAB IN FIBROBLAST GROWTH FACTOR RECEPTOR 2B (FGFR2B) POSITIVE FIRST-LINE GASTRIC CANCER

30-06-2025
SHANGHAI & CAMBRIDGE, MASS.--(BUSINESS WIRE)--ZAI LAB LIMITED (NASDAQ: ZLAB; HKEX: 9688) TODAY ANNOU...
Více zde

ZAI LAB PRESENTS NEW PRECLINICAL DATA FOR ZL-1503, AN IL-13/IL-31R BISPECIFIC ANTIBODY FOR THE TREATMENT OF ATOPIC DERMATITIS, AT EAACI CONGRESS 2025

13-06-2025
SHANGHAI & CAMBRIDGE, MASS.--(BUSINESS WIRE)--ZAI LAB LIMITED (NASDAQ: ZLAB; HKEX: 9688) TODAY ANNOU...
Více zde

ZAI LAB PRESENTS POSITIVE PHASE 1 DATA FOR ZL-1310, A DLL3-TARGETED ADC, DEMONSTRATING ROBUST ANTI-TUMOR ACTIVITY AND SAFETY IN PATIENTS WITH EXTENSIVE-STAGE SMALL CELL LUNG CANCER AT 2025 ASCO ANNUAL MEETING

02-06-2025
SHANGHAI & CAMBRIDGE, MASS.--(BUSINESS WIRE)--ZAI LAB LIMITED (NASDAQ: ZLAB; HKEX: 9688) TODAY ANNOU...
Více zde

ZAI LAB AND NOVOCURE ANNOUNCE RESULTS FROM THE PHASE 3 PANOVA-3 TRIAL OF TUMOR TREATING FIELDS (TTFIELDS) THERAPY FOR PANCREATIC CANCER TO BE PRESENTED AT 2025 ASCO ANNUAL MEETING

31-05-2025
SHANGHAI & CAMBRIDGE, MASS. & BAAR, SWITZERLAND--(BUSINESS WIRE)--ZAI LAB LIMITED (NASDAQ: ZLAB; HKE...
Více zde

ZAI LAB ANNOUNCES PARTICIPATION IN INVESTOR CONFERENCES IN JUNE 2025

30-05-2025
SHANGHAI & CAMBRIDGE, MASS.--(BUSINESS WIRE)--ZAI LAB LIMITED (NASDAQ: ZLAB; HKEX: 9688) TODAY ANNOU...
Více zde

ZAI LAB RECEIVES U.S. FDA FAST TRACK DESIGNATION FOR ZL-1310, A DLL3-TARGETED ANTIBODY-DRUG CONJUGATE, FOR TREATMENT OF EXTENSIVE-STAGE SMALL CELL LUNG CANCER

19-05-2025
SHANGHAI & CAMBRIDGE, MASS.--(BUSINESS WIRE)--ZAI LAB LIMITED (NASDAQ: ZLAB; HKEX: 9688) TODAY ANNOU...
Více zde

ZAI LAB ANNOUNCES FIRST QUARTER 2025 FINANCIAL RESULTS AND RECENT CORPORATE UPDATES

08-05-2025
SHANGHAI & CAMBRIDGE, MASS.--(BUSINESS WIRE)--ZAI LAB LIMITED (NASDAQ: ZLAB; HKEX: 9688) TODAY ANNOU...
Více zde

ZAI LAB PRESENTS DATA HIGHLIGHTING POTENTIAL OF INTERNALLY DEVELOPED, NEXT-GENERATION ONCOLOGY THERAPIES AT AACR 2025

25-04-2025
SHANGHAI & CAMBRIDGE, MASS.--(BUSINESS WIRE)--ZAI LAB LIMITED (NASDAQ: ZLAB; HKEX: 9688) WILL PRESEN...
Více zde

ZAI LAB ANNOUNCES ACCEPTANCE OF SUPPLEMENTAL NEW DRUG APPLICATION FOR REPOTRECTINIB FOR PATIENTS WITH NTRK-POSITIVE SOLID TUMORS

21-04-2025
SHANGHAI & CAMBRIDGE, MASS.--(BUSINESS WIRE)--ZAI LAB LIMITED (NASDAQ: ZLAB; HKEX: 9688) TODAY ANNOU...
Více zde

ZAI LAB TO PRESENT NEW DATA FROM INTERNALLY DEVELOPED, NEXT-GENERATION ONCOLOGY CANDIDATES AT AACR 2025 ANNUAL MEETING

26-03-2025
SHANGHAI & CAMBRIDGE, MASS.--(BUSINESS WIRE)--ZAI LAB LIMITED (NASDAQ: ZLAB; HKEX: 9688) TODAY ANNOU...
Více zde

ZAI LAB ANNOUNCES ACCEPTANCE OF BIOLOGICS LICENSE APPLICATION FOR TIVDAK FOR THE TREATMENT OF PATIENTS WITH RECURRENT OR METASTATIC CERVICAL CANCER

12-03-2025
SHANGHAI & CAMBRIDGE, MASS.--(BUSINESS WIRE)--ZAI LAB LIMITED (NASDAQ: ZLAB; HKEX: 9688) TODAY ANNOU...
Více zde

ZAI LAB ANNOUNCES PARTICIPATION IN INVESTOR CONFERENCES IN MARCH 2025

03-03-2025
SHANGHAI & CAMBRIDGE, MASS.--(BUSINESS WIRE)--ZAI LAB LIMITED (NASDAQ: ZLAB; HKEX: 9688) TODAY ANNOU...
Více zde

close

Datum Typ Otevřít EDGAR Stáhnout dokument
2025-11-06 00:00:008-KStáhnout
2025-11-06 00:00:0010-QStáhnout
2025-10-16 01:00:008-KStáhnout
2025-10-16 00:00:008-KStáhnout
2025-08-07 01:00:008-KStáhnout
2025-08-07 01:00:0010-QStáhnout
2025-08-07 00:00:008-KStáhnout
2025-08-07 00:00:0010-QStáhnout
2025-06-18 01:00:008-KStáhnout
2025-06-18 00:00:008-KStáhnout
2025-05-08 01:00:008-KStáhnout
2025-05-08 01:00:0010-QStáhnout
2025-05-08 00:00:008-KStáhnout
2025-05-08 00:00:0010-QStáhnout
2025-02-27 00:00:008-KStáhnout
2025-02-27 00:00:0010-KStáhnout
2025-02-26 23:00:008-KStáhnout
2025-02-26 23:00:0010-KStáhnout
2025-01-03 00:00:008-KStáhnout
2025-01-02 23:00:008-KStáhnout
2024-11-15 00:00:008-KStáhnout
2024-11-14 23:00:008-KStáhnout
2024-11-13 00:00:008-KStáhnout
2024-11-12 23:00:008-KStáhnout
2024-08-06 01:00:008-KStáhnout
2024-08-06 01:00:0010-QStáhnout
2024-08-06 00:00:008-KStáhnout
2024-08-06 00:00:0010-QStáhnout
2024-07-09 01:00:008-KStáhnout
2024-07-09 00:00:008-KStáhnout
2024-06-18 01:00:008-KStáhnout
2024-06-18 00:00:008-KStáhnout
2024-06-11 01:00:008-KStáhnout
2024-06-11 00:00:008-KStáhnout
2024-05-08 01:00:008-KStáhnout
2024-05-08 01:00:0010-QStáhnout
2024-05-08 00:00:008-KStáhnout
2024-05-08 00:00:0010-QStáhnout
2024-02-27 00:00:008-KStáhnout
2024-02-27 00:00:0010-KStáhnout
2024-02-26 23:00:008-KStáhnout
2024-02-26 23:00:0010-KStáhnout
2024-02-08 00:00:008-KStáhnout
2024-02-07 23:00:008-KStáhnout
2023-11-07 00:00:008-KStáhnout
2023-11-07 00:00:0010-QStáhnout
2023-11-06 23:00:008-KStáhnout
2023-11-06 23:00:0010-QStáhnout
2023-08-07 01:00:008-KStáhnout
2023-08-07 01:00:0010-QStáhnout
2023-08-07 00:00:008-KStáhnout
2023-08-07 00:00:0010-QStáhnout
2023-07-06 01:00:008-KStáhnout
2023-07-06 00:00:008-KStáhnout
2023-06-30 01:00:008-KStáhnout
2023-06-30 00:00:008-KStáhnout
2023-06-20 01:00:008-KStáhnout
2023-06-20 00:00:008-KStáhnout
2023-06-06 01:00:008-KStáhnout
2023-06-06 00:00:008-KStáhnout
2023-05-09 01:00:008-KStáhnout
2023-05-09 01:00:0010-QStáhnout
2023-05-09 00:00:008-KStáhnout
2023-05-09 00:00:0010-QStáhnout
2023-03-31 01:00:008-KStáhnout
2023-03-31 00:00:008-KStáhnout
2023-03-01 00:00:008-KStáhnout
2023-03-01 00:00:0010-KStáhnout
2023-02-28 23:00:008-KStáhnout
2023-02-28 23:00:0010-KStáhnout
2023-01-09 00:00:008-KStáhnout
2023-01-08 23:00:008-KStáhnout
2023-01-05 00:00:008-KStáhnout
2023-01-04 23:00:008-KStáhnout
2022-11-09 00:00:008-KStáhnout
2022-11-09 00:00:0010-QStáhnout
2022-11-08 23:00:008-KStáhnout
2022-11-08 23:00:0010-QStáhnout
2022-10-28 01:00:008-KStáhnout
2022-10-28 00:00:008-KStáhnout
2022-09-27 01:00:008-KStáhnout
2022-09-27 00:00:008-KStáhnout
2022-08-09 01:00:008-KStáhnout
2022-08-09 01:00:0010-QStáhnout
2022-08-09 00:00:008-KStáhnout
2022-08-09 00:00:0010-QStáhnout
2022-08-03 01:00:008-KStáhnout
2022-08-03 00:00:008-KStáhnout
2022-06-22 01:00:008-KStáhnout
2022-06-22 00:00:008-KStáhnout
2022-05-31 01:00:008-KStáhnout
2022-05-31 00:00:008-KStáhnout
2022-05-10 01:00:008-KStáhnout
2022-05-10 01:00:0010-QStáhnout
2022-05-10 00:00:008-KStáhnout
2022-05-10 00:00:0010-QStáhnout
2022-04-21 01:00:008-KStáhnout
2022-04-21 00:00:008-KStáhnout
2022-04-01 01:00:008-KStáhnout
2022-04-01 00:00:008-KStáhnout
2022-03-28 01:00:008-KStáhnout
2022-03-28 00:00:008-KStáhnout
2022-03-15 00:00:008-KStáhnout
2022-03-14 23:00:008-KStáhnout
2022-03-01 00:00:008-KStáhnout
2022-03-01 00:00:0010-KStáhnout
2022-02-28 23:00:008-KStáhnout
2022-02-28 23:00:0010-KStáhnout
2022-01-06 00:00:008-KStáhnout
2022-01-05 23:00:008-KStáhnout
2021-12-22 00:00:008-KStáhnout
2021-12-21 23:00:008-KStáhnout
2021-12-16 00:00:008-KStáhnout
2021-12-15 23:00:008-KStáhnout
2021-12-03 00:00:008-KStáhnout
2021-12-02 23:00:008-KStáhnout
2021-11-22 00:00:008-KStáhnout
2021-11-21 23:00:008-KStáhnout
2021-11-09 00:00:008-KStáhnout
2021-11-09 00:00:0010-QStáhnout
2021-11-08 23:00:008-KStáhnout
2021-11-08 23:00:0010-QStáhnout
2021-11-05 00:00:008-KStáhnout
2021-11-04 23:00:008-KStáhnout
2021-10-20 01:00:008-KStáhnout
2021-10-20 00:00:008-KStáhnout
2021-10-19 01:00:008-KStáhnout
2021-10-19 00:00:008-KStáhnout
2021-10-18 01:00:008-KStáhnout
2021-10-18 00:00:008-KStáhnout
2021-08-09 01:00:008-KStáhnout
2021-08-09 01:00:0010-QStáhnout
2021-08-09 00:00:008-KStáhnout
2021-08-09 00:00:0010-QStáhnout
2021-06-24 01:00:008-KStáhnout
2021-06-24 00:00:008-KStáhnout
2021-06-16 01:00:008-KStáhnout
2021-06-16 00:00:008-KStáhnout
2021-06-01 01:00:008-KStáhnout
2021-06-01 00:00:008-KStáhnout
2021-05-10 01:00:008-KStáhnout
2021-05-10 01:00:0010-QStáhnout
2021-05-10 00:00:008-KStáhnout
2021-05-10 00:00:0010-QStáhnout
2021-04-23 01:00:008-KStáhnout
2021-04-23 00:00:008-KStáhnout
2021-04-21 01:00:008-KStáhnout
2021-04-21 00:00:008-KStáhnout
2021-04-19 01:00:008-KStáhnout
2021-04-19 00:00:008-KStáhnout
2021-04-13 01:00:008-KStáhnout
2021-04-13 00:00:008-KStáhnout
2021-03-31 01:00:008-KStáhnout
2021-03-31 00:00:008-KStáhnout
2021-03-01 00:00:008-KStáhnout
2021-03-01 00:00:0010-KStáhnout
2021-02-28 23:00:008-KStáhnout
2021-02-28 23:00:0010-KStáhnout
2021-01-11 00:00:008-KStáhnout
2021-01-10 23:00:008-KStáhnout
2021-01-06 00:00:008-KStáhnout
2021-01-05 23:00:008-KStáhnout
2021-01-04 00:00:008-KStáhnout
2021-01-03 23:00:008-KStáhnout
preloader